These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20015360)

  • 1. Human synthetic lethal inference as potential anti-cancer target gene detection.
    Conde-Pueyo N; Munteanu A; Solé RV; Rodríguez-Caso C
    BMC Syst Biol; 2009 Dec; 3():116. PubMed ID: 20015360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SynLethDB: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets.
    Guo J; Liu H; Zheng J
    Nucleic Acids Res; 2016 Jan; 44(D1):D1011-7. PubMed ID: 26516187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignancy of Cancers and Synthetic Lethal Interactions Associated With Mutations of Cancer Driver Genes.
    Wang X; Zhang Y; Han ZG; He KY
    Medicine (Baltimore); 2016 Feb; 95(8):e2697. PubMed ID: 26937901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mslar: Microbial synthetic lethal and rescue database.
    Zhu SB; Jiang QH; Chen ZG; Zhou X; Jin YT; Deng Z; Guo FB
    PLoS Comput Biol; 2023 Jun; 19(6):e1011218. PubMed ID: 37289843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Link synthetic lethality to drug sensitivity of cancer cells.
    Wang R; Han Y; Zhao Z; Yang F; Chen T; Zhou W; Wang X; Qi L; Zhao W; Guo Z; Gu Y
    Brief Bioinform; 2019 Jul; 20(4):1295-1307. PubMed ID: 29300844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer.
    Srihari S; Singla J; Wong L; Ragan MA
    Biol Direct; 2015 Oct; 10():57. PubMed ID: 26427375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syn-lethality: an integrative knowledge base of synthetic lethality towards discovery of selective anticancer therapies.
    Li XJ; Mishra SK; Wu M; Zhang F; Zheng J
    Biomed Res Int; 2014; 2014():196034. PubMed ID: 24864230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranking novel cancer driving synthetic lethal gene pairs using TCGA data.
    Ye H; Zhang X; Chen Y; Liu Q; Wei J
    Oncotarget; 2016 Aug; 7(34):55352-55367. PubMed ID: 27438146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSSLdb: Discovery of cancer-specific synthetic lethal interactions based on machine learning and statistic inference.
    Dou Y; Ren Y; Zhao X; Jin J; Xiong S; Luo L; Xu X; Yang X; Yu J; Guo L; Liang T
    Comput Biol Med; 2024 Mar; 170():108066. PubMed ID: 38310806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposal for a new therapy for drug-resistant malaria using Plasmodium synthetic lethality inference.
    Lee SJ; Seo E; Cho Y
    Int J Parasitol Drugs Drug Resist; 2013 Dec; 3():119-28. PubMed ID: 24533301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SL
    Liu Y; Wu M; Liu C; Li XL; Zheng J
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(3):748-757. PubMed ID: 30969932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic lethals in HIV: ways to avoid drug resistance : Running title: Preventing HIV resistance.
    Petitjean M; Badel A; Veitia RA; Vanet A
    Biol Direct; 2015 Apr; 10():17. PubMed ID: 25888435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential synthetic lethal genes to p53 using a computational biology approach.
    Wang X; Simon R
    BMC Med Genomics; 2013 Sep; 6():30. PubMed ID: 24025726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting synthetic lethal interactions in human cancers using graph regularized self-representative matrix factorization.
    Huang J; Wu M; Lu F; Ou-Yang L; Zhu Z
    BMC Bioinformatics; 2019 Dec; 20(Suppl 19):657. PubMed ID: 31870274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the landscape of synthetic lethal interactions in liver cancer.
    Yang C; Guo Y; Qian R; Huang Y; Zhang L; Wang J; Huang X; Liu Z; Qin W; Wang C; Chen H; Ma X; Zhang D
    Theranostics; 2021; 11(18):9038-9053. PubMed ID: 34522226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lethal combination for cancer cells: synthetic lethality screenings for drug discovery.
    Ferrari E; Lucca C; Foiani M
    Eur J Cancer; 2010 Nov; 46(16):2889-95. PubMed ID: 20724143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-omics characterization of synthetic lethality-related molecular features: implications for SL-based therapeutic target screening.
    Weng S; Ruan H
    FEBS J; 2023 Mar; 290(6):1477-1480. PubMed ID: 36461713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-omic measurement of mutually exclusive loss-of-function enriches for candidate synthetic lethal gene pairs.
    Wappett M; Dulak A; Yang ZR; Al-Watban A; Bradford JR; Dry JR
    BMC Genomics; 2016 Jan; 17():65. PubMed ID: 26781748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NSF4SL: negative-sample-free contrastive learning for ranking synthetic lethal partner genes in human cancers.
    Wang S; Feng Y; Liu X; Liu Y; Wu M; Zheng J
    Bioinformatics; 2022 Sep; 38(Suppl_2):ii13-ii19. PubMed ID: 36124790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CM-viewer: Visualizing interaction network of co-mutated and mutually exclusively mutated cancer genes.
    Zhou N; Hu Z; Wu C; Bao J
    Biosystems; 2018 Apr; 166():37-42. PubMed ID: 29278730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.